Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases-Reference-Cited by-同舟云学术

Discovery of 2,6-disubstituted pyrazine derivatives as inhibitors of CK2 and PIM kinases

Published:2018-05 Issue:8 Volume:28 Page:1336-1341
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Gingipalli Lakshmaiah,Block Michael H.,Bao Larry,Cooke Emma,Dakin Les A.,Denz Christopher R.,Ferguson Andrew D.,Johannes Jeffrey W.^ORCID,Larsen Nicholas A.,Lyne Paul D.,Pontz Timothy W.,Wang Tao,Wu Xiaoyun,Wu Allan,Zhang Hai-Jun,Zheng Xiaolan,Dowling James E.,Lamb Michelle L.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death

2. CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response

3. Protein kinase CK2 – A key suppressor of apoptosis

4. The Protein Kinase CK2 Phosphorylates SNAP190 to Negatively Regulate SNAPC DNA Binding and Human U6 Transcription by RNA Polymerase III

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3;Bioorganic & Medicinal Chemistry Letters;2024-02

2. Comprehensive Insights that Targeting PIM for Cancer Therapy: Prospects and Obstacles;Journal of Medicinal Chemistry;2024-01-02

3. Proviral integration site for Moloney murine leukemia virus-1 (PIM-1) kinase inhibitors;Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy;2024

4. Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3;2023-12-04

5. Pharmacological activity and mechanism of pyrazines;European Journal of Medicinal Chemistry;2023-10